Risk and Benefit of Statins in Stroke Secondary Prevention

ISSN: 1875-6212 (Online)
ISSN: 1570-1611 (Print)

Volume 15, 6 Issues, 2017

Download PDF Flyer

Current Vascular Pharmacology

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 36th of 63 in Peripheral Vascular Disease
  • 125th of 253 in Pharmacology & Pharmacy

Submit Abstracts Online Submit Manuscripts Online

Dimitri P. Mikhailidis
Academic Head, Department of Clinical Biochemistry
Royal Free Hospital Campus
University College London Medical School
University College London (UCL)
Pond Street
London, NW3 2QG

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.374
5 - Year: 2.25

Risk and Benefit of Statins in Stroke Secondary Prevention

Current Vascular Pharmacology, 11(6): 812-816.

Author(s): Patrice Laloux.

Affiliation: Department of Neurology, CHU Mont-Godinne, Institute of Neurosciences, Avenue Therasse 1, B- 5530 Yvoir, Belgium.


Statin is now recommended in secondary prevention after stroke or transient ischemic attacks to reduce the risk of a new stroke or major cardiovascular events. However, some issues about the extent of the benefit in some stroke patients and the risk of cerebral hemorrhage remain debated. This review shows that statins are significantly effective in decreasing the risk of further strokes despite an increase in the risk of brain hemorrhage. A significant benefit was observed in men and women, in aged patients and possibly to a greater extent in patients with carotid artery stenosis. Intensive statin therapy lowering the LDL-cholesterol beyond the cut-off value of 1.8 mmol/L (70 mg/dl) seems to be more effective than less intensive treatment and without an increased risk of side effects. Overall, statins are well tolerated. Further prospective studies should clarify whether the effect is of the same magnitude in small vessel disease and how to select the patients to reduce the risk of cerebral hemorrhage.


Carotid stenosis, cerebral hemorrhage, cholesterol, risk, statins, stroke, therapy, treatment.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 11
Issue Number: 6
First Page: 812
Last Page: 816
Page Count: 5
DOI: 10.2174/157016111106140128113121
Price: $58

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science